These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 15026333)

  • 1. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
    Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
    Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
    Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
    Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
    Bastian PJ; Ellinger J; Heukamp LC; Kahl P; Müller SC; von Rücker A
    Eur Urol; 2007 Mar; 51(3):665-74; discussion 674. PubMed ID: 16956712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.
    Bastian PJ; Palapattu GS; Yegnasubramanian S; Rogers CG; Lin X; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    J Urol; 2008 Feb; 179(2):529-34; discussion 534-5. PubMed ID: 18076941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.
    Vanaja DK; Ehrich M; Van den Boom D; Cheville JC; Karnes RJ; Tindall DJ; Cantor CR; Young CY
    Cancer Invest; 2009 Jun; 27(5):549-60. PubMed ID: 19229700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG
    J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer].
    Bastian PJ; Nakayama M; De Marzo AM; Nelson WG
    Urologe A; 2004 May; 43(5):573-9. PubMed ID: 15029477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma.
    Jerónimo C; Henrique R; Campos PF; Oliveira J; Caballero OL; Lopes C; Sidransky D
    J Clin Pathol; 2003 Jan; 56(1):52-5. PubMed ID: 12499435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
    Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
    J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
    Bastian PJ; Yegnasubramanian S; Palapattu GS; Rogers CG; Lin X; De Marzo AM; Nelson WG
    Eur Urol; 2004 Dec; 46(6):698-708. PubMed ID: 15548435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
    Lin X; Tascilar M; Lee WH; Vles WJ; Lee BH; Veeraswamy R; Asgari K; Freije D; van Rees B; Gage WR; Bova GS; Isaacs WB; Brooks JD; DeWeese TL; De Marzo AM; Nelson WG
    Am J Pathol; 2001 Nov; 159(5):1815-26. PubMed ID: 11696442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.
    Nakayama M; Bennett CJ; Hicks JL; Epstein JI; Platz EA; Nelson WG; De Marzo AM
    Am J Pathol; 2003 Sep; 163(3):923-33. PubMed ID: 12937133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.